ArticleNeoplasia (New York, N.Y.)2015

Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.

Maxim A Shevtsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.